Shivanand Kumatagi Reflects on His Visit to Rela Hospital
Shivanand Kumatagi, Development Officer (India) at ICCBBA, shared on LinkedIn:
”Productive Visit to Rela Hospital, Chennai
I had the opportunity to visit Rela Hospital, Chennai and it was a pleasure engaging with the Transfusion Medicine team on the importance of adopting ISBT128 standardized labeling for blood and cellular therapy products.
We discussed how the increasing use of advanced technologies—including automation, barcodes, and RFID—brings tremendous benefits but also introduces new challenges related to accuracy, interoperability, and traceability.
This is exactly where standardized, globally recognized ISBT128 play a crucial role.
They help overcome these obstacles by ensuring consistency, reducing errors, and enabling seamless communication across diverse platforms and systems.
It was encouraging to see the team’s positive response and their commitment to aligning with international standards and global best practices to enhance patient safety.
Looking forward to continuing this conversation and supporting the further strengthening of transfusion services.”
Stay updated with Hemostasis Today.
-
Jul 12, 2026, 08:50Where the Hemophilia Community Comes Together at ISTH 2026 – EAHAD
-
Jul 12, 2026, 08:2210 Posts Not To Miss from ISTH 2026, Part 1
-
Jul 12, 2026, 07:58Brian O Mahony: Could NXT-007 Minimize the Need for Perioperative FVIII
-
Jul 12, 2026, 07:50Shayan Mohammadmoradi: Connecting the Next Generation of Hemostasis Researchers at ISTH 2026
-
Jul 12, 2026, 07:42Alexandra Yakusheva: ThrombInnov Debuts at ISTH 2026 with a Focus on Translational Research
-
Jul 12, 2026, 07:34Wolfgang Miesbach: ISTH 2026 Explores the Next Generation of APS Diagnostics
-
Jul 12, 2026, 07:28Sara Zalghout: ISTH 2026 Highlights Progress in Thromboinflammation Research
-
Jul 12, 2026, 07:13Ekaterina Balaian: Finding Healing Through Art at ISTH 2026
-
Jul 12, 2026, 06:59Maaike Sybil Jongen: Flow Cytometry for Platelet Phenotyping at ISTH 2026